Clinical Update on Nursing Home Medicine: 2012

Journal of the American Medical Directors Association

Volumn 13, Issue 7, 2012, Pages 581-594

  Messinger Rapport, Barbara J ^a   Cruz Oliver, Dulce M ^b   Thomas, David R ^b   Morley, John E ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Clostridium difficile associated diarrhea; Falls; Frailty; Hypertension; Peripheral arterial disease (PAD); Probiotics

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CITALOPRAM; DIPYRIDAMOLE; DIURETIC AGENT; ESCITALOPRAM; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; METHYLPHENIDATE; MIRTAZAPINE; NITRENDIPINE; PROBIOTIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLOSTRIDIUM DIFFICILE INFECTION; COGNITIVE THERAPY; COMORBIDITY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; FALL RISK ASSESSMENT; FALLING; FRAIL ELDERLY; GERIATRIC CARE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFECTIOUS DIARRHEA; LOW DRUG DOSE; NURSING HOME; NURSING HOME PATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PROGNOSIS; PSYCHOTHERAPY; RATING SCALE; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SODIUM INTAKE; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 84865568794     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.06.006     Document Type: Article

References (201)

1. Simonson W., Han L.F., Davidson H.E. Hypertension treatment and outcomes in US nursing homes: Results from the US National Nursing Home survey. J Am Med Dir Assoc 2011, 12:44-49.
2. Koka M., Joseph J., Aronow W.S. Adequacy of control of hypertension in an academic nursing home. J Am Med Dir Assoc 2007, 8:538-540.
3. Morley J.E. Hypertension: Is is overtreated in the elderly?. J Am Med Dir Assoc 2010, 11:147-152.
4. Messinger-Rapport B.J., Thomas D.R., Gammack J.K., Morley J.E. Clinical update on nursing home medicine: 2009. J Am Med Dir Assoc 2009, 10:530-553.
5. Aronow W.S. Hypertension in the nursing home. J Am Med Dir Assoc 2008, 9:486-490.
6. Aronow W.S. Drug therapy of older persons with hypertension. J Am Med Dir Assoc 2006, 7:193-196.
7. Anonymous Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (shep). Shep cooperative research group. JAMA 1991, 265:3255-3264.
8. Staessen J.A., Fagard R., Thijs L., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
9. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887-1898.
10. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981-2997. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
11. Pepine C.J., Handberg E.M., Cooper-DeHoff R.M., et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003, 290:2805-2816.
12. Denardo S.J., Gong Y., Nichols W.W., et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: An invest substudy. Am J Med 2010, 123:719-726.
13. Somes G., Pahor M., Shorr R., Cushman W., et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159:2004-2009.
14. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003, 289:2560-2571.
15. Mancia G., Laurent S., Agabiti-Rosei E., et al. Reappraisal of European guidelines on hypertension management: A European society of hypertension task force document. J Hypertens 2009, 27:2121-2158.
16. Mancia G., De Backer G., Dominiczak A., et al. 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462-1536.
17. Cushman W.C., Evans G.W., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585. Accord Study Group.
18. Appel L.J., Wright J.T., Greene T., et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010, 363:918-929.
19. Aronow W.S., Fleg J.L., Pepine C.J., et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. J Am Soc Hypertens 2011, 5:259-352.
20. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988, 297:319-328. Intersalt Cooperative Research Group.
21. Donovan D.S., Solomon C.G., Seely E.W., et al. Effect of sodium intake on insulin sensitivity. Am J Physiol 1993, 264(5 Pt 1):E730-E734.
22. du Cailar G., Ribstein J., Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002, 15:222-229.
23. Devine A., Criddle R.A., Dick I.M., et al. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995, 62:740-745.
24. Fiocco A.J., Shatenstein B., Ferland G., et al. Sodium intake and physical activity impact cognitive maintenance in older adults: The NuAge study. Neurobiol Aging 2012, 33. 829.e21-e28.
25. Graudal N.A., Hubeck-Graudal T., Jurgens G. Effects of low-sodium diet vs. High-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012, 25:1-15.
26. Cook N.R., Obarzanek E., Cutler J.A., et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: The trials of hypertension prevention follow-up study. Arch Intern Med 2009, 169:32-40.
27. Cook N.R., Cutler J.A., Obarzanek E., et al. Long-term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334:885-888.
28. Appel L.J., Espeland M.A., Easter L., et al. Effects of reduced sodium intake on hypertension control in older individuals: Results from the trial of nonpharmacologic interventions in the elderly (tone). Arch Intern Med 2001, 161:685-693.
29. Paterna S., Gaspare P., Fasullo S., et al. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: Is sodium an old enemy or a new friend?. Clin Sci 2008, 114:221-230.
30. Morgan T., Adam W., Gillies A., et al. Hypertension treated by salt restriction. Lancet 1978, 1:227-230.
31. He F.J., MacGregor G.A. Salt reduction lowers cardiovascular risk: Meta-analysis of outcome trials. Lancet 2011, 378:380-382.
32. Cohen H.W., Hailpern S.M., Alderman M.H. Sodium intake and mortality follow-up in the third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med 2008, 23:1297-1302.
33. Ekinci E.I., Clarke S., Thomas M.C., et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
34. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
35. Thomas M.C., Moran J., Forsblom C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
36. Yang Q., Liu T., Kuklina E.V., et al. Sodium and potassium intake and mortality among us adults: Prospective data from the third national health and nutrition examination survey. Arch Intern Med 2011, 171:1183-1191.
37. O'Donnell M.J., Yusuf S., Mente A., et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
38. Lennie T.A., Song E.K., Wu J.R., et al. Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. J Card Fail 2011, 17:325-330.
39. Arcand J., Ivanov J., Sasson A., et al. A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: A prospective follow-up study. Am J Clin Nutr 2011, 93:332-337.
40. Dong J., Li Y., Yang Z., Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. CJASN 2010, 5:240-247.
41. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program. JAMA 1991, 265:3255-3264. SHEP Cooperative Research Group.
42. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat). JAMA 2002, 288:2981-2997. ALLHAT Collaborative Research Group.
43. Cheng T.W., Chen T.F., Yip P.K., et al. Comparison of behavioral and psychological symptoms of Alzheimer's disease among institution residents and memory clinic outpatients. Int Psychogeriatr/IPA 2009, 21:1134-1141. Epub 2009/09/09.
44. Lenze E.J. Treating depression in older adults with dementia. Journal of the American Geriatrics Society 2011, 59:754-755. Epub 2011/04/16.
45. Seitz D., Purandare N., Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: A systematic review. Int Psychogeriatr/IPA 2010, 22:1025-1039. Epub 2010/06/05.
46. Lawlor B. Managing behavioural and psychological symptoms in dementia. Br J Psychiatr 2002, 181:463-465. Epub 2002/11/29.
47. Olin J.T., Katz I.R., Meyers B.S., et al. Provisional diagnostic criteria for depression of Alzheimer disease: Rationale and background. Am J Geriatr Psychiatry 2002, 10:129-141. Epub 2002/04/02.
48. Brommelhoff J.A., Spann B.M., Go J.L., Mack W.J., et al. Striatal hypodensities, not white matter hypodensities on CT, are associated with late-onset depression in Alzheimer's disease. J Aging Res 2011, 2011:187219. Epub 2011/09/29.
49. Eccles M., Clarke J., Livingstone M., Freemantle N., et al. North of England evidence based guidelines development project: Guideline for the primary care management of dementia. BMJ 1998, 317:802-808. Epub 1998/09/18.
50. Majic T., Pluta J.P., Mell T., et al. The pharmacotherapy of neuropsychiatric symptoms of dementia: A cross-sectional study in 18 homes for the elderly in Berlin. Deutsches Arzteblatt Int 2010, 107:320-327. Epub 2010/06/03.
51. Arbus C., Gardette V., Bui E., et al. Antidepressant use in Alzheimer's disease patients: Results of the REAL.FR cohort. Int Psychogeriatr/IPA 2010, 22:120-128. Epub 2009/09/09.
52. Harris T., Carey I.M., Shah S.M., et al. Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales. J Am Med Dir Assoc 2012, 13:41-47. Epub 2011/04/01.
53. Coupland C., Dhiman P., Morriss R., et al. Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ 2011, 343:d4551. Epub 2011/08/04.
54. Baldwin R.C., Anderson D., Black S., et al. Guideline for the management of late-life depression in primary care. Int J Geriatr Psychiatry 2003, 18:829-838. Epub 2003/09/02.
55. Nelson J.C., Devanand D.P. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. J Am Geriatr Soc 2011, 59:577-585. Epub 2011/04/02.
56. Banerjee S., Hellier J., Dewey M., et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): A randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011, 378:403-411. Epub 2011/07/19.
57. Padala P.R., Burke W.J., Shostrom V.K., et al. Methylphenidate for apathy and functional status in dementia of the Alzheimer type. J Am J Geriatr Psychiatry 2010, 18:371-374. Epub 2010/03/12.
58. Kang H.Y., Bae Y.S., Kim E.H., et al. An integrated dementia intervention for Korean older adults. J Psychosocial Nurs Mental Health Serv 2010, 48:42-50. Epub 2010/11/09.
59. Phillips L.J., Reid-Arndt S.A., Pak Y. Effects of a creative expression intervention on emotions, communication, and quality of life in persons with dementia. Nurs Res 2010, 59:417-425. Epub 2010/11/05.
60. Tappen R.M., Williams C.L. Therapeutic conversation to improve mood in nursing home residents with Alzheimer's disease. Res Gerontolo Nurs 2009, 2:267-275. Epub 2010/01/19.
61. Spector A., Thorgrimsen L., Woods B., et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised controlled trial. Br J Psychiatry 2003, 183:248-254. Epub 2003/09/02.
62. Livingston G., Johnston K., Katona C., et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005, 162:1996-2021. Epub 2005/11/03.
63. Woods B., Aguirre E., Spector A.E., Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012, 2:CD005562. Epub 2012/02/18.
64. Wilson KC, Mottram PG, Vassilas CA. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008(1):CD004853.
65. Hertzer N.R., Beven E.G., Young J.R., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984, 199:223-233.
66. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
67. Haskal A.T., Hirsch Z.J., Hertzer N.R., et al. ACC/AHA2005 practice guidelines for the management of patients' peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. Circulation 2006, 113:e463-e465.
68. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines. Circulation 2006, 113:e463-e654.
69. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
70. National Center for Health Statistics. NHANES 20037-2004 public data general release file documentation. Data collection procedures. http://www.cdc.gov/nchs/data/nhanes/nhanes%2003%2004/general%20data%20release%20doc%2003-04.pdf.
71. Heart disease and stroke statistics-2008 update. Circulation 2008, 117:e25-e146. American Heart Association.
72. Weitz J.I., Bryne J., Clagett G.P., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 1996, 94:3026-3049.
73. McKenna M., Wolfson S., Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991, 87:119-128.
74. Newman A.B., Shemanski L., Manolio T.A., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999, 19:538-545.
75. Quick C.R.G., Cotton L.T. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982, 69(Suppl):S24-S26.
76. Jonason T., Bergstrom R. Cessation of smoking in patients with intermittent claudication. Acta Med Scand 1987, 221:253-260.
77. Momsen A.H., Jensen M.B., Norager C.B., et al. Drug therapy for improving walking distance in intermittent claudication: A systematic review and meta-analysis of robust randomised controlled studies. European J Vasc Endovasc Surg 2009, 38:463-474.
78. Berger J.S., Krantz M.J., Kittelson J.M., Hiatt W.R. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trials. JAMA 2009, 301:1909-1919.
79. Jaegar K. Cardiovascular and Cerebrovascular Disease. American Heart Association website. Available at ) posted Feb 21, 2012. Accessed June 6, 2012. http://newsroom.heart.org.pr/aha/american-heart-association-launches-229260.aspx.
80. Girolami B., Bernardi E., Prins M.H., et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: A meta-analysis. Arch Int Med 1999, 159:337-345.
81. Robless P., Mikhailidis D.P., Stansby G.P. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2008, 1:CD003748.
82. Nawalany M. Endovascular therapy for limb salvage. Surg Clin N Am 2010, 90:1215-1225.
83. Murphy T.P., Hirsch A.T., Ricotta J.J., et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) Study: Rationale and methods. J Vasc Surg 2008, 47:1356-1363.
84. Schrezenmeir J., de Vrese M. Probiotics, prebiotics, and synbiotics-Approaching a definition. Am J Clin Nutr 2001, 73(2 Suppl):361S-364S.
85. Borchers A.T., Selmi C., Meyers F.J., et al. Probiotics and immunity. J Gastroenterol 2009, 44:26-46.
86. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
87. Dendukuri N., Costa V., McGregor M., Brophy J.M. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: A systematic review. Can Med Assoc J 2005, 173:167-170.
88. McFarland L.V., Surawicz C.M., Greenberg R.N., et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994, 271:1913-1918.
89. Surawicz C.m., McFarland L.V., Greenberg R.N., et al. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000, 31:1012-1027.
90. Lewis S.J., Potts L.F., Barry R.E. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998, 36:171-174.
91. Plummer S., Weaver M.A., Harris J.C., Dee P., et al. Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C difficile diarrhoea. Int Microbiol 2004, 7:59-62.
92. Thomas M.R., Litin S.C., Osmon D.R., et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial. Mayo Clin Proc 2001, 76:883-889.
93. Wullt M., Hagslatt M.L., Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: A double-blind, placebo-controlled trial. Scand J Infect Dis 2003, 35:365-367.
94. Tung J.M., Dolovich L.R., Lee C.H. Prevention of Clostridium difficile infection with Saccharomyces boulardii: A systematic review. Can J Gastroenterol 2009, 23:817-821.
95. Lawrence S.J., Korzenik J.R., Mundy L.M. Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 2005, 94(Pt 9):905-906.
96. Hickson M., D'Souza A.L., Muthu N., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial. BMJ 2007, 335:80.
97. Gao X.W., Mubasher M., Fang C.Y., et al. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010, 105:1636-16341.
98. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
99. Rolland Y., Aquino J.P., Andrieu S., et al. Identification of the main domains for quality of care and clinical research in nursing homes. J Nutr Health Aging 2011, 15:410-424.
100. Gobbens R.J., Luijkx K.G., Wijnen-Sponselee M.T., Schols J.M. In search of an integral conceptual definition of frailty: Opinions of experts. J Am Med Dir Assoc 2010, 11:338-343.
101. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. The Tilburg Frailty Indicator: Psychometric properties. J Am Med Dir Assoc 2010, 11:344-355.
102. Peters L.L., Boter H., Buskens E., Slaets J.P. Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalize elderly people. J Am Med Dir Assoc 2012, 13:546-551.
103. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012, 13:121-126.
104. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011, 12:249-256.
105. Rolland Y., Czerwinski S., Abellan van Kan, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008, 12:433-450.
106. Bauer J.M., Kaiser M.J., Sieber C.C. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008, 9:545-551.
107. Morley J.E., Abbatecola A.M., Argiles J.M., et al. Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011, 12:403-409.
108. van Kan G.A., Cderbaum J.M., Cesari M., et al. Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia Research). J Nutr Health Aging 2011, 15:834-846.
109. Chumlea W.C., Cesari M., Evans W.J., et al. International Working Group on Sarcopenia Task Force Members. Sarcopenia: Designing phase IIB trials. J Nutr Health Aging 2011, 15:450-455.
110. Rolland Y., Lauwers-Cances V., Cristini C., et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The PIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 2009, 89:1895-1900.
111. Morley J.E. Diabetes, sarcopenia and frailty. Clin Geriatr Med 2008, 24:455-469.
112. Newman A.B., Gottdiener J.S., Mcburnie M.A., et al. Cardiovascular Health Study Research Group. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001, 56:M158-M166.
113. Fried L.P., Ferrucci L., Darer J., et al. Untangling the concepts of disability, frailty and comorbidity: Implications for improved targeting and care. J Gerontol Biol Sci Med Sci 2004, 59:255-263.
114. Landi F., Russo A., Liperoti R., et al. Anorexia, physical function, and incident disability among the frail elderly population: Results from the ilSIRENTE study. J Am Med Dir Assoc 2010, 11:268-274.
115. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
116. Cereda E., Pedrolli C., Zagami A., et al. Body mass index and mortality in institutionalized elderly. J Am Med Dir Assoc 2011, 12:174-178.
117. Argiles J.M., Anker S.D., Evans W.J., et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010, 11:229-230.
118. Morley J.E. Clinical practice in nursing homes as a key for progress. J Nutr Health Aging 2010, 14:586-593.
119. Morley J.E. Polypharmacy in the nursing home. J Am Med Dir Assoc 2009, 10:289-291.
120. Bokce Kutsal Y., Barak A., Atalay A., et al. Polypharmacy in the elderly: A multicenter study. J Am Med Dir Assoc 2009, 10:486-490.
121. Tamura Bk, Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. J Am Med Dir Assoc 2011, 12:326-330.
122. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatment-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010, 11:475-484.
123. Morley J.E. Frailty: Diagnosis and management. J Nutr Health Aging 2011, 15:667-670.
124. Thakur M., Blazer D.G. Depression in long-term care. J Am Med Dir Assoc 2008, 9:82-87.
125. Morley J.E. Depression in nursing home residents. J Am Med Dir Assoc 2010, 11:301-303.
126. Damian J., Pastor-Barriuso R., Valderrama-Gama E. Descriptive epidemiology of undetected depression in institutionalized older people. J Am Med Dir Assoc 2010, 11:312-319.
127. Hanlon J.T., Handler S.M., Castle N.G. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc 2010, 11:320-324.
128. Seitz D.P., Adunuri N., Gill S.S., Rochon P.A. Prevalence of dementia and cognitive impairment among older adults with hip fractures. J Am Med Dir Assoc 2011, 12:556-564.
129. Kerwin D., Claus T.H. Severe Alzheimer's disease: Treatment effects on function and care requirements. J Am Med Dir Assoc 2011, 12:99-104.
130. Cruz-Oliver D.M., Morley J.E. Early detection of cognitive impairment: Do screening tests help?. J Am Med Dir Assoc 2010, 11:1-6.
131. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
132. Ensrud K.E., Ewing S.K., Taylor B.C., et al. for the Study of Osteoporotic Fractures Research Group. Frailty and risk of falls, fracture and mortality in older women: The study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007, 62:744-751.
133. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
134. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008, 12:29-37.
135. Woo J., Leung J., Morley J.E. Comparison of frailty indicators based on clinical phenotype versus the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012, 60:1478-1486.
136. Hyde Z., Flicker L., Almeida O.P., et al. Low free testosterone predicts frailty in older men: The health in men study. J Clin Endocrinol Metab 2010, 95:3165-3172.
137. Lopez D., Flicker L., Dobson A. Validation of the frail scale in a cohort of older Australian women. J Am Geriatr Soc 2012, 60:171-173.
138. Morley J.E., Malmstrom T.K., Miller D.K. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012, 16:601-608.
139. Rockwood K., Abeysundera M.J., Mitnitski A. How should we grade frailty in nursing home patients?. J Am Med Dir Assoc 2007, 8:595-603.
140. Theou O., Stathokostas L., Roland K.P., et al. The effectiveness of exercise intervention for the management of frailty: A systematic review. J Aging Res 2011, 2011:569194.
141. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012, 13:24-30.
142. Rolland Y., Abellan van Kan G., Vellas B. Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 2008, 9:390-405.
143. Morley J.E. The magic of exercise. J Am Med Dir Assoc 2008, 9:375-377.
144. Yamada M., Arai H., Sonoda T., Aoyama T. Community-based exercise program is cost-effective by preventing care and disability in Japanese frailty older adults. J Am Med Dir Assoc 2012, 13:507-511.
145. Ferrando A.A., Paddon-Jones D., Hays N.P., et al. EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly. Clin Nutr 2010, 29:18-23.
146. Kortebein P., Symons T.B., Ferrando A., et al. Functional impact of 10 days of bed rest in healthy older adults. J Gerontol A Biol Sci Med Sci 2008, 63:1076-1081.
147. Morley J.E. Anabolic steroids and frailty. J Am Med Dir Assoc 2010, 11:533-536.
148. Morley J.E. Should frailty be treated with testosterone?. Aging Male 2011, 14:1-3.
149. Chapman I.M., Visvanathan R., Hammond A.J., et al. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009, 89:880-889.
150. Chahla E.J., Hayek M.E., Morley J.E. Testosterone replacement therapy and cardiovascular risk factors modification. Aging Male 2011, 14:83-90.
151. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment and monitoring of late-onset hypodonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008, 159:507-514.
152. Dalton J.T., Barnette K.G., Bohl C.E., et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011, 2:153-161.
153. Huang Z., Chen X., Chen D. Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation. Cell Signal 2011, 23:1441-1446.
154. Morley J.E. Sarcopenia in the elderly. Fam Pract 2012, 29(Suppl 1):i44-i48.
155. Wilson M.M., Thomas D.R., Rubenstein L.Z., et al. Appetite assessment: Simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005, 82:1074-1081.
156. Rolland Y., Perrin A., Gardette V., et al. Screening older people at risk of malnutrition or malnourished using the Simplified Nutritional Appetite Questionnaire (SNAQ): A comparison with the Mini-Nutritional Assessment (MNA) tool. J Am Med Dir Assoc 2012, 13:31-34.
157. Yeh S.S., Lovitt S., Schuster M.W. Pharmacological treatment of geriatric cachexia: Evidence and safety in perspective. J Am Med Dir Assoc 2007, 8:363-377.
158. Chasen M., Hirschman S.Z., Bhargava R. Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia. J Am Med Dir Assoc 2011, 12:62-67.
159. Wilson M.M., Philpot C., Morley J.E. Anorexia of aging in long-term care: Is dronabinol an effective appetite stimulant?-A pilot study. J Nutr Health Aging 2007, 11:195-198.
160. Tolson D., Rolland Y., Andrieu S., et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011, 12:184-189.
161. Rapp K., Becker C., Cameron I.D., et al. Epidemiology of falls in residential aged care: Analysis of more than 70,000 falls from residents of Bavarian nursing homes. J Am Med Dir Assoc 2012, 13:187.e1-187.e6.
162. Vu M.Q., Weintraub N., Rubenstein L.Z. Falls in the nursing home: Are they preventable?. J Am Med Dir Assoc 2004, 5:401-406.
163. Morley J.E. Hip fractures. J Am Med Dir Assoc 2010, 11:81-83.
164. Heinrich S., Rapp K., Rissmann U., et al. Service use and costs of incident femoral fractures in nursing home residents in Germany: The Bavarian Fall and fracture Prevention Project (BF22). J Am Med Dir Assoc 2011, 12:459-466.
165. Morley J.E. Falls and fractures. J Am Med Dir Assoc 2007, 8:276-278.
166. Grimbergen Y.A., Munneke M., Bloem B.R. Falls in Parkison's disease. Curr Opin Neurol 2004, 17:405-415.
167. Morley J.E., Rolland Y., Tolson D., Vellas B. Increasing awareness of the factors producing falls: The mini falls assessment. J Am Med Dir Assoc 2012, 13:87-90.
168. Gama Z.A., Medina-Pirapeix F., Saturno P.J. Ensuring evidence-based practices for falls prevention in a nursing home setting. J Am Med Dir Assoc 2011, 12:398-402.
169. Choi M., Hector M. Effectiveness of intervention programs in preventing falls: A systematic review of recent 10 years and meta-analysis. J Am Med Dir Assoc 2012, 13:188.e13-188.e21.
170. Faes M.C., Reelick M.F., Melis R.J., et al. Multifactorial fall prevention for pairs of frail community-dwelling older fallers and their informal caregivers: A dead end for complex interventions in the frailest fallers. J Am Med Dir Assoc 2011, 12:451-458.
171. Neyens J.C., van Haastregt J.C., Dijcks B.P., et al. Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: A systematic review of RCTs. J Am Med Dir Assoc 2011, 12:410-425.
172. Quigley P., Bulat T., Kurtzman E., et al. Fall prevention and injury protection for nursing home residents. J Am Med Dir Assoc 2010, 11:284-293.
173. Tolson D., Morley J.E. Physical restrains: Abusive and harmful. J Am Med Dir Assoc 2012, 13:311-313.
174. Becker C., Rapp K. Fall prevention in nursing homes. Clin Geriatr Med 2010, 26:693-704.
175. Voyer P., Richard S., McCusker J., et al. Detection of delirium and its symptoms by nurses working in a long-term care facility. J Am Med Dir Assoc 2012, 13:264-271.
176. Jones Rn, Kiely Dk, Marcantonio E.R. Prevalence of delirium on admission to postacute care is associated with a higher number of nursing home deficiencies. J Am Med Dir Assoc 2010, 11:253-256.
177. Laurila J.V., Strendberg T.E., Tilvis R.S., Pitkala K.H. Detecting delirium using different diagnostic criteria among long-term care residents. J Am Med Dir Assoc 2009, 10:511-512.
178. Flaherty J.H., Shay K., Weir C., et al. The development of a mental status vital sign for use across the spectrum of care. J Am Med Dir Assoc 2009, 10:379-380.
179. Eeles E., Rockwood K. Delirium in the long-term care setting: Clinical and research challenges. J Am Med Dir Assoc 2008, 9:157-161.
180. Whitney J., Close J.C., Jackson S.H., Lord S.R. Understanding risk of falls in people with cognitive impairment living in residential care. J Am Med Dir Assoc 2012, 13:535-540.
181. Wagner L.M., Dionne J.C., Zive J.R., Rochon P.A. Fall risk care processes in nursing home facilities. J Am Med Dir Assoc 2011, 12:426-430.
182. Jalbert J.J., Eaton C.B., Miller S.C., Lapane K.L. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010, 11:120-127.
183. Rizzoli R., Cooper C., Reginster J.Y., et al. Antidepressant medications and osteoporosis. Bone 2012, [Epub ahead of print].
184. Targownik L.E., Leslie W.D. The relationship among proton pump inhibitors, bone disease and fracture. Expert Opin Drug Saf 2011, 10:901-912.
185. Pizzigalli L., Filippini A., Ahmaidi S., et al. Prevention of falling risk in elderly people: The relevance of muscular strength and symmetry of lower limbs in postural stability. J Strength Cond Res 2011, 25:567-574.
186. Leung D.P., Chan C.K., Tsang H.W., et al. Tai Chi as an intervention to improve balance and reduce falls in older adults: A systematic and meta-analytical review. Altern Ther Health med 2011, 17:40-48.
187. Sherrington C., Tiedemann A., Fairhall N., et al. Exercise to prevent falls in older adults: An updated meta-analysis and best practice recommendations. NSW Public Health Bull 2011, 22:78-83.
188. Iwanczyk L., Weintraub N.T., Rubenstein L.Z. Orthostatic hypotension in the nursing home setting. J Am Med Dir Assoc 2006, 7:163-167.
189. Morley J.E. Hypertension: Is it overtreated in the elderly?. J Am Med Dir Assoc 2010, 11:147-152.
190. Reelick M.F., Faes M.C., Esselink R.A., et al. How to perform a preplanned process evaluation for complex interventions in geriatric medicine: Exemplified with the process evaluation of a complex falls-prevention program for community-dwelling frail older fallers. J Am Med Dir Assoc 2011, 12:331-336.
191. Morley J.E. Postprandial hypotension-The ultimate Big Mac attack. J Gerontol A Biol Sci Med Sci 2001, 56:M741-M743.
192. Cronin H., Kenny R.A. Cardiac causes for falls and their treatment. Clin Geriatr Med 2010, 26:539-567.
193. Islam T., Peiris P., Copeland R.J., et al. Vitamin D: Lessons from the veterans population. J Am Med Dir Assoc 2011, 12:257-262.
194. McKinney J.D., Bailey B.A., Garrett L.H., et al. Relationship between vitamin D status and ICU outcomes in veterans. J Am Med Dir Assoc 2011, 12:208-211.
195. Gaddipati V.C., Bailey B.A., Kuriacose R., et al. The relationship of vitamin D status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease. J Am Med Dir Assoc 2011, 12:58-61.
196. Grant W.B., Peiris A.N. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc 2010, 11:617-628.
197. Peiris A.N., Bailey B., Manning T., et al. Testing for vitamin D deficiency in veterans-Is there a seasonal bias?. J Am Med Dir Assoc 2010, 11:128-131.
198. Morley J.E. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc 2007, 8:69-70.
199. Gau J.T. Prevalence of vitamin D deficiency/insufficiency practice patterns in nursing homes. J Am Med Dir Assoc 2010, 11:296.
200. Demontiero O., Herrmann M., Duque G. Supplementation with vitamin D and calcium in long-term care residents. J Am Med Dir Assoc 2011, 12:190-194.
201. Duque G., Mallet L., Roberts A., et al. To treat or not to treat, that is the question: Proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-term Care institutions, Saint-Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc 2006, 7:435-441.